Drug Candidate
NLY03
Summary
Orally active, neuroprotective agents for Neurodegenerative Disease
Mechanism of Action
Targets in the parthanatos cascade
Indication
Stroke / Parkinson’s Disease
Development Stage
Discovery ~ Preclinical
NLY03
NLY03
Orally active, neuroprotective agents for Neurodegenerative Disease
Targets in the parthanatos cascade
Stroke / Parkinson’s Disease
Discovery ~ Preclinical